Quinine for nocturnal leg cramps
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
OBJECTIVE: With respect to the use of quinine for the treatment of nocturnal leg cramps, to determine whether the findings of a previously performed meta-analysis of published data are altered with the addition of unpublished data, and whether publication bias is present in this area.
DESIGN: A meta-analysis of eight (four published and four unpublished) randomized, double-blind, placebo-controlled trials, seven of which had a crossover design.
SETTING: Randomized trials that were available as of July 1997.
SUBJECTS: Ambulatory patients (659) who suffered from regular nocturnal leg cramps.
MAIN RESULTS: When individual patient data from all crossover studies were pooled, persons had 3.60 (95% confidence interval [CI] 2.15, 5.05] fewer cramps in a 4-week period when taking quinine compared with placebo. This compared with an estimate of 8.83 fewer cramps (95% CI 4.16, 13.49) from pooling published studies alone. The corresponding relative risk reductions were 21% (95% CI 12%, 30%) and 43% (95% CI 21%, 65%), respectively. Compared with placebo, the use of quinine was associated with an increased incidence of side effects, particularly tinnitus. Publication bias is present in the reporting of the efficacy of quinine for this indication, as almost all published studies reported larger estimates of its efficacy than did unpublished studies.
CONCLUSIONS: This study confirms that quinine is efficacious in the prevention of nocturnal leg cramps. However, its benefit may not be as large as reported from the pooling of published studies alone. Given the side effect profile of quinine, nonpharmacologic therapy (e.g., regular passive stretching of the affected muscle) is the best first-line treatment. For persons who find this ineffective and whose quality of life is significantly affected, a trial of quinine is warranted. Prescribing physicians must closely monitor the risks and benefits in individual patients. Publication bias is present in this area even though there is controversy about the role of quinine in the treatment of leg cramps. To minimize the possibility of this bias, persons performing medication-related meta-analyses should seek high-quality unpublished data from drug regulatory agencies and pharmaceutical companies.
- Hall AJ. Cramp and salt balance in ordinary life. Lancet. 1947;3:231–3. CrossRef
- Leclerc KM, Landry FJ. Benign nocturnal leg cramps. Current controversies over the use of quinine. Postgrad Med. 1996;99:177–84.
- Man-Son-Hing M, Wells G. Meta-analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people. BMJ. 1995;310:13–7.
- Sidorov J. Quinine sulfate for leg cramps: does it work? J Am Geriatr Soc. 1993;41:498–500.
- Connolly PS, Shirley EA, Wassen JH, Nierenberg DW. Treatment of nocturnal leg cramps. A crossover trial of quinine vs. vitamin E. Arch Intern Med. 1992;152:1877–80. CrossRef
- Fung MC, Holbrook JH. Placebo-controlled trial of quinine therapy for nocturnal leg cramps. West J Med. 1989;151:42–4.
- Warburton A, Royston JP, O’Neill CJA, et al. A quinine a day keeps the leg cramps away? Br J Clin Pharmacol. 1987;23:459–65.
- Cook DJ, Guyatt GH, Ryan G, et al. Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA. 1993;269:2749–53. CrossRef
- Easterbrook PJ, Berlin JA, Gopalan T, Matthews DR. Publication bias and dissemination of clinical research. Lancet. 1991;337:867–72. CrossRef
- Chalmers TC, Levin H, Sacks HS, Reitmen D, Berrier J, Nagalingam R. Meta-analysis of clinical trials as a scientific discipline, I: control of bias and comparison with large co-operative trials. Stat Med. 1987;6:315–25. CrossRef
- Nightingale SL. Quinine for nocturnal leg cramps. ACP J Club. 1995;123:86. Letter.
- Drug products for the treatment and/or prevention of nocturnal leg muscle cramps for over-the-counter human use. Fed Reg. 1994;59:43234–52.
- Leo Winter Associates, Inc. Final medican report and data summary analysis and final statistical report on double blind randomized crossover study of Q-VELR versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. (Norwalk, Conn.: Bio-Products; 1986). Unpublished report.
- Hays R, Goodman JJ. Clinical trial of the efficacy of quinine sulfate in the treatment of nocturnal leg muscle cramps, protocol 86-48. (Memphis, Tenn.: Scholl Pharmaceuticals; 1986). Unpublished report.
- Bottner M. Clinical trial of the efficacy of quinine sulfate in the treatment of nocturnal leg muscle cramps, protocol 84-46. (Memphis, Tenn.: Scholl Pharmaceuticals; 1984). Unpublished report.
- Clinical evaluation of Q-VEL in patients with nocturnal leg muscle cramps. (New York, NY: Bio-Products; 1984). Unpublished report.
- A short-term, randomized, double-blind, parallel study of Q-Vel vs. quinine sulfate vs. vitamin E vs. placebo in the prevention and treatment of nocturnal leg cramps. (Edison, NJ: CIBA Pharmaceuticals; 1988). Unpublished report.
- Maule B. Nocturnal cramps: quinine versus folklore. Practitioner. 1990;234:420–1.
- Jansen PHP, Veenhuizen KCW, Verbeek ALM, Staatman H. Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. J Neurol Sci. 1994;122:157–61. CrossRef
- Gorlich HD, von Gablenz E, Steinberg HW. Treatment of nocturnal leg cramps. A multi-center, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittelforschung. 1991;411:167–75.
- Mackie MA, Davidson J. Prescribing of quinine and cramp inducing drugs in general practice. BMJ. 1995;311:1541.
- Felson DT. Bias in meta-analytic research. J Clin Epidemiol. 1992;45:885–92. CrossRef
- Daniell HW. Simple cure for nocturnal leg cramps. N Engl J. Med. 1979;301:216.
- Quinine for nocturnal leg cramps
Journal of General Internal Medicine
Volume 13, Issue 9 , pp 600-606
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- leg cramps
- publication bias
- Industry Sectors
- Author Affiliations
- 1. Received from the Department of Medicine, University of Ottawa, Ottawa, Ont., Canada
- 2. the Geriatric Assessment Unit and Clinical Epidemiology Unit, Loeb Research Institute, Ottawa Civic Hospital, Ottawa, Ont., Canada